☆ 4.7 Article

Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Related references

Note: Only part of the references are listed.

Article Pharmacology & Pharmacy

Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of randomized trial data

Harri Hemila et al.

Summary: The meta-analysis found that nasal carrageenan significantly increased the recovery rate of cold patients, with effects on colds caused by different viruses. Additionally, carrageenan could effectively reduce the duration of longer-lasting colds. Further research on nasal iota-carrageenan is warranted to explore its potential effects on COVID-19.

PHARMACOLOGY RESEARCH & PERSPECTIVES (2021)

Add to Collection

Article Medicine, General & Internal

The Saliva of Probands Sucking an Iota-Carrageenan Containing Lozenge Inhibits Viral Binding and Replication of the Most Predominant Common Cold Viruses and SARS-CoV-2

Martina Morokutti-Kurz et al.

Summary: The study found that sucking an iota-carrageenan containing lozenge can release sufficient iota-carrageenan into the saliva of healthy subjects to neutralize and inactivate the most common respiratory virus families and pandemic SARS-CoV-2. The lozenges could potentially reduce viral load at the infection site, limiting transmission within a population and translocation to the lower respiratory tract.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)

Add to Collection

Review Cell Biology

Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies

Simin Seyedpour et al.

Summary: This study systematically evaluated recent in vitro and in vivo investigations targeting SARS-CoV-2 cell entry, finding that SARS-CoV-2 primarily enters host cells through the S protein utilizing ACE2 or CD147 as receptors. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms mainly focus on targeting virus receptors on the host, neutralizing spike protein, interfering with virus fusion to host cells, and disrupting endosomal and non-endosomal dependent pathways.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Add to Collection

Article Chemistry, Analytical

N- and O-Glycosylation of the SARS-CoV-2 Spike Protein

Miloslav Sanda et al.

Summary: The outbreak of the Covid-19 pandemic has caused the current global health crisis, prompting the need for detailed studies on SARS-CoV-2 proteins to develop effective antiviral compounds and vaccines. The glycosylation of the spike (S) protein plays a significant role in its proteolytic activation, expanding the current knowledge in this area.

ANALYTICAL CHEMISTRY (2021)

Add to Collection

Article Multidisciplinary Sciences

Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2

Yejin Jang et al.

Summary: The study demonstrated that lambda-carrageenan from marine red algae exhibited broad spectrum antiviral activity against influenza A and B viruses as well as SARS-CoV-2, without causing toxicity to host cells. It acts by targeting viral attachment to cell surface receptors and preventing virus entry, showing promise as a potential antiviral agent for preventing respiratory virus infections.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021

Summer E. Galloway et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Physiology

Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures

Desiree Schuetz et al.

Summary: The study found that carrageenan in certain nasal and mouth sprays can effectively inhibit SARS-CoV-2 infection, reducing the risk of viral spread.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Dami A. Collier et al.

Summary: The B.1.1.7 variant of SARS-CoV-2 exhibited reduced neutralization by vaccines and antibodies from recovered COVID-19 patients, with a more substantial loss seen when introducing the E484K mutation. This mutation poses a threat to the efficacy of the BNT162b2 vaccine.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Constantinos Kurt Wibmer et al.

Summary: The SARS-CoV-2 virus in the B.1.351 variant discovered in South Africa can evade neutralization by most antibodies when expressed, but does not affect binding by convalescent plasma. This suggests the potential for reinfection with antigenically distinct variants and predicts reduced efficacy of spike-based vaccines.

NATURE MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro

Martina Morokutti-Kurz et al.

Summary: Iota-carrageenan has shown to inhibit cell entry of SARS-CoV-2 virus and replication, with potential antiviral effects demonstrated in vitro. Clinical studies have also indicated that iota-carrageenan can reduce severity and duration of symptoms caused by various respiratory viruses, suggesting it may be an effective prophylaxis or treatment for SARS-CoV-2 infections.

PLOS ONE (2021)

Add to Collection

Article Multidisciplinary Sciences

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Nicholas G. Davies et al.

Summary: A new variant of SARS-CoV-2 has emerged in England, with a higher reproduction number and potential for large resurgences of COVID-19 cases. Without stringent control measures, it is projected that COVID-19 hospitalizations and deaths in England for the first 6 months of 2021 will exceed those in 2020. The variant has spread globally and exhibited similar transmission increases in Denmark, Switzerland, and the United States.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2

Kentaro Uemura et al.

Summary: The study aimed to develop a virus-susceptible human cell line for SARS-CoV-2 research, with findings showing that MRC5/ACE2 cells will be crucial in the development of specific anti-viral therapeutics and in assisting vaccine development to combat SARS-CoV-2 infections.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Detection of B.1.351 SARS-CoV-2 Variant Strain - Zambia, December 2020

Mulenga Mwenda et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Microbiology

Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization

Pengfei Wang et al.

Summary: The emerging Brazilian variant P.1 shows increased resistance to antibody neutralization, posing a threat to current antibody therapies, but has less impact on the effectiveness of protective vaccines.

CELL HOST & MICROBE (2021)

Add to Collection

Article Multidisciplinary Sciences

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Erik Volz et al.

Summary: Genetic and testing data from England indicate that the SARS-CoV-2 variant B.1.1.7 has a transmission advantage over other lineages, showing a rapid expansion during autumn 2020. Analysis of S gene target failures (SGTF) in community-based diagnostic PCR testing suggests that B.1.1.7 is more transmissible than non-variant of concern lineages and has a significant transmission advantage, with a reproduction number 50% to 100% higher. Additionally, cases of B.1.1.7 appear to include a larger share of under 20-year-olds compared to non-variant cases.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel Dedicated to Patients Care with COVID-19 Disease

Juan Manuel Figueroa et al.

Summary: The pilot study indicates that a nasal spray containing Iota-Carrageenan has significant efficacy in preventing COVID-19 in healthcare workers managing patients with COVID-19, with a relative risk reduction of 79.8% and an absolute risk reduction of 4%.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)

Add to Collection

Article Virology

Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2

Maximilian Grosse et al.

Summary: This study found that quinine exhibited more effective antiviral activity against SARS-CoV-2 with lower toxicity compared to CQN and H-CQN. It showed antiviral activity in different cell lines, indicating its potential as a treatment option for SARS-CoV-2.

VIRUSES-BASEL (2021)

Add to Collection

Article Virology

The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus

Yeong Jun Kim et al.

Summary: A new variant of SARS-CoV-2 B.1.351 lineage is of global concern for its potential increase in transmissibility and resistance to neutralizing antibodies. This study found that the B.1.351 lineage variant showed significantly increased infectivity and enhanced cell-cell fusion compared to the Wuhan strains, particularly with the K417N and E484K mutations. In terms of antibody efficacy, Imdevimab was more effective in neutralizing the B.1.351 lineage pseudoviruses containing specific mutations, compared to Casirivimab.

VIRUSES-BASEL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta

Janina Auth et al.

Summary: Wheat Germ Agglutinin (WGA) shows antiviral activity against SARS-CoV-2 and its variants, possibly by neutralizing viral entry. It may be effective for prophylaxis or treatment of SARS-CoV-2 infections.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Chemistry, Medicinal

Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model

Sahar Alsaidi et al.

Summary: The study found that iota and lambda carrageenan exhibit the most potent antiviral activity against SARS-CoV-1 and SARS-CoV-2, and combinations of griffithsin and carrageenan show synergistic effects, including against recent SARS-CoV-2 mutations. The combination is a promising candidate for preventing or treating infections by SARS-CoV-1 and SARS-CoV-2.

MARINE DRUGS (2021)

Add to Collection

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals

Matthias Becker et al.

Summary: This study characterizes the antibody response from vaccinated, infected, and uninfected individuals against emerging variants of concern of SARS-CoV-2, indicating reduced neutralization of a South African isolate. High IgG titers in the saliva of vaccinees suggest reduced transmission potential.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Public, Environmental & Occupational Health

The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review

Andri Frediansyah

Summary: Carrageenan has demonstrated strong antiviral activity against various coronaviruses and non-coronaviruses, although clinical trials are needed to evaluate its specific efficacy for COVID-19 treatment despite some positive results in conjunction with other oral medications.

CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2021)

Add to Collection

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Add to Collection

Article Virology

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

Yushun Wan et al.

JOURNAL OF VIROLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

Yixuan J. Hou et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

Site-specific glycan analysis of the SARS-CoV-2 spike

Yasunori Watanabe et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Xiuyuan Ou et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Editorial Material Medicine, General & Internal

Reducing risks from coronavirus transmission in the home-the role of viral load

Paul Little et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Letter Medicine, General & Internal

Droplets and Aerosols in the Transmission of SARS-CoV-2

Matthew Meselson

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Immunology

Distribution of Transmission Potential During Nonsevere COVID-19 Illness

Nabin K. Shrestha et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection

Article Respiratory System

Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue

Jennifer A. Aguiar et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Bette Korber et al.

CELL (2020)

Add to Collection

Review Virology

Natural product-derived phytochemicals as potential agents against coronaviruses: A review

Janice S. Mani et al.

VIRUS RESEARCH (2020)

Add to Collection

Article Medicine, General & Internal

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

Peter Horby et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Nutrition & Dietetics

Plant Foods, Antioxidant Biomarkers, and the Risk of Cardiovascular Disease, Cancer, and Mortality: A Review of the Evidence

Dagfinn Aune

ADVANCES IN NUTRITION (2019)

Add to Collection

Article Medicine, General & Internal

Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis

Christine Graf et al.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2018)

Add to Collection

Article Medicine, General & Internal

Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat

Martina Morokutti-Kurz et al.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2017)

Add to Collection

Article Microbiology

Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus

Keith Levendosky et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

Add to Collection

Review Chemistry, Applied

Review for carrageenan-based pharmaceutical biomaterials: Favourable physical features versus adverse biological effects

Jingjing Liu et al.

CARBOHYDRATE POLYMERS (2015)

Add to Collection

Article Multidisciplinary Sciences

Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer Immunotherapy

Min Luo et al.

SCIENTIFIC REPORTS (2015)

Add to Collection

Article Multidisciplinary Sciences

Non-Clinical Safety Evaluation of Intranasal Iota-Carrageenan

Alexandra Hebar et al.

PLOS ONE (2015)

Add to Collection

Article Multidisciplinary Sciences

The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model

Martina Morokutti-Kurz et al.

PLOS ONE (2015)

Add to Collection

Article Respiratory System

Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial

R. Eccles et al.

RESPIRATORY RESEARCH (2015)

Add to Collection

Article Respiratory System

Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials

Martin Koenighofer et al.

MULTIDISCIPLINARY RESPIRATORY MEDICINE (2014)

Add to Collection

Article Respiratory System

Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial

Martin Ludwig et al.

RESPIRATORY RESEARCH (2013)

Add to Collection

Article Integrative & Complementary Medicine

Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold

Tamas Fazekas et al.

BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)

Add to Collection

Article Chemistry, Applied

Effects of structural peculiarities of carrageenans on their immunomodulatory and anticoagulant activities

Irina M. Yermak et al.

CARBOHYDRATE POLYMERS (2012)

Add to Collection

Article Biochemistry & Molecular Biology

Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds

Sumit Bhattacharyya et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2010)

Add to Collection

Article Multidisciplinary Sciences

Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection

Andreas Leibbrandt et al.

PLOS ONE (2010)

Add to Collection

Article Respiratory System

Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold

Ron Eccles et al.

RESPIRATORY RESEARCH (2010)

Add to Collection

Review Chemistry, Applied

Carrageenans: Biological properties, chemical modifications and structural analysis - A review

Vanessa Leiria Campo et al.

CARBOHYDRATE POLYMERS (2009)

Add to Collection

Article Fisheries

Immunomodulation by carrageenans in the white shrimp Litopenaeus vannamei and its resistance against Vibrio alginolyticus

Su-Tuen Yeh et al.

AQUACULTURE (2008)

Add to Collection

Article Virology

Iota-Carrageenan is a potent inhibitor of rhinovirus infection

Andreas Grassauer et al.

VIROLOGY JOURNAL (2008)

Add to Collection

Article Virology

Interference in dengue virus adsorption and uncoating by carrageenans

Laura B. Talarico et al.

VIROLOGY (2007)

Add to Collection

Article Oncology

Immunomodulation and antitumor activity of κ-carrageenan oligosaccharides

Huamao Yuan et al.

CANCER LETTERS (2006)

Add to Collection

Article Microbiology

Carrageenan is a potent inhibitor of papillomavirus infection

Christopher B. Buck et al.

PLOS PATHOGENS (2006)

Add to Collection

Article Pharmacology & Pharmacy

Effect of low molecular λ-carrageenan from Chondrus ocellatus on antitumor H-22 activity of 5-Fu

GF Zhou et al.

PHARMACOLOGICAL RESEARCH (2006)

Add to Collection

Article Pharmacology & Pharmacy

The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus

K Nyberg et al.

ANTIVIRAL RESEARCH (2004)

Add to Collection

Article Microbiology

Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China

Z Zhao et al.

JOURNAL OF MEDICAL MICROBIOLOGY (2003)

Add to Collection

Article Virology

Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120

M Moulard et al.

JOURNAL OF VIROLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.